Our results indicated that IMB-6G promoted autophagosome accumulation from the early stage of treatment but blocked autophagic flux through attenuation of lysosomal cathepsins activity in pancreatic cancer cells. The gene discussed is CTSS; the disease is pancreatic neoplasm.